Moxie Dwight

Officer at Revance Therapeutics, Inc.

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
6
Latest Mar 18, 2024
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Mar 9, 2023 2023

    Sold 18,496 shares at $31.59 ($584k)

    Moxie Dwight, SVP, GC & Secretary

    Sold 25% of holdings ($2.3M position)55,547 shares leftFollows a Form 144Filing

  2. 2 Form 144 notice Revance Therapeutics, Inc.Notice
    May 12, 2023 +64 days

    Filed to sell 22,000 shares ($735k)

    Moxie Dwight, Officer

    No 10b5-1 plan2x usual sizeFiling

  3. 3 Form 4 sale Revance Therapeutics, Inc.No plan
    May 15, 2023 +3 days

    Sold 21,401 shares at $34.55 ($739k)

    Moxie Dwight, SVP, GC & Secretary

    No 10b5-1 planSold 23.6% of holdings ($3.1M position)69,165 shares left1.9x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice Revance Therapeutics, Inc.Notice
    Sep 5, 2023 +113 days

    Filed to sell 23,853 shares ($425k)

    Moxie Dwight, Officer

    10b5-1 plan1.6x usual sizeFiling

  5. 5 Form 144 notice Revance Therapeutics, Inc.Notice
    Sep 6, 2023 +1 day

    Filed to sell 11,000 shares ($188k)

    Moxie Dwight, Officer

    10b5-1 plan0.7x usual sizeFiling

  6. 6 Form 4 sale Revance Therapeutics, Inc.Routine
    Sep 6, 2023 same day

    Sold 34,853 shares at $17.57 ($612k)

    Moxie Dwight, SVP, GC & Secretary

    10b5-1 planSold 44.2% of holdings ($1.4M position)44,066 shares left2.4x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice Revance Therapeutics, Inc.Notice
    Mar 18, 2024 +194 days

    Filed to sell 8,500 shares ($47k)

    Moxie Dwight, Officer

    No 10b5-1 plan0.4x usual sizeFiling

  8. 8 Form 4 sale Revance Therapeutics, Inc.No plan
    Mar 18, 2024 same day

    Sold 8,125 shares at $5.04 ($41k)

    Moxie Dwight, CLO & GC

    No 10b5-1 planSold 5.6% of holdings ($736k position)137,815 shares left0.4x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Moxie Dwight
Source
Mar 18, 2024Mar 19, 2024Revance Therapeutics, Inc.CLO & GCForm 4 sale8,125$41k5.6%No planSEC
Mar 18, 2024Mar 18, 2024Revance Therapeutics, Inc.OfficerForm 144 notice8,500$47kNoticeSEC
Sep 6, 2023Sep 7, 2023Revance Therapeutics, Inc.SVP, GC & SecretaryForm 4 sale34,853$612k44.2%RoutineSEC
Sep 6, 2023Sep 6, 2023Revance Therapeutics, Inc.OfficerForm 144 notice11,000$188kNoticeSEC
Sep 5, 2023Sep 5, 2023Revance Therapeutics, Inc.OfficerForm 144 notice23,853$425kNoticeSEC
May 15, 2023May 16, 2023Revance Therapeutics, Inc.SVP, GC & SecretaryForm 4 sale21,401$739k23.6%No planSEC
May 12, 2023May 12, 2023Revance Therapeutics, Inc.OfficerForm 144 notice22,000$735kNoticeSEC
Mar 9, 2023Mar 9, 2023Revance Therapeutics, Inc.SVP, GC & SecretaryForm 4 sale18,496$584k25.0%Plan not statedSEC
Mar 8, 2023Mar 8, 2023Revance Therapeutics, Inc.OfficerForm 144 notice20,000$660kNoticeSEC
Sep 14, 2022Sep 16, 2022Revance Therapeutics, Inc.SVP, GC & SecretaryForm 4 sale11,000$298k25.8%UnusualSEC
Sep 27, 2021Sep 28, 2021Revance Therapeutics, Inc.SVP, GC & SecretaryForm 4 sale1,675$50k3.4%Plan not statedSEC